|

HB2198 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Hinge Bio1

Indications

  • Extra-renal Lupus (ERL)1
  • Lupus Nephritis (LN)1
  • Systemic Lupus Erthematosus (SLE)1
  • Lupus1

Other1 trial

A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.